McKesson Publishes Fiscal Q2 2027 Earnings Call Transcript
Bitget2026/11/05 23:21- McKesson raised fiscal 2027 adjusted diluted EPS guidance to $45.60-$46.40 from $44.20-$45 during its second-quarter earnings call.
- CEO Brian S. Tyler, CFO Kenny K. Cheung and Paula Adkison attended the November 4, 2026, call.
- Quarterly adjusted diluted EPS rose 18% to $11.68; revenue increased 8% to $111 billion.
- The completed $2.25 billion Precision Medicine Group acquisition is expected to contribute $0.10-$0.20 to adjusted diluted EPS.
- A proposed $1.4 billion investment for 49% of Option Care Health is expected to close in the first half of calendar 2027.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BTC surpasses $71,000
Euro Falls as US Dollar gains on inflation concerns, Fed rate hike bets
AMD (AMD.US) Enters the "Trillion-Dollar Quantum Track": Partners with PsiQuantum to Develop Fault-Tolerant, Practical-Scale Quantum Infrastructure and Plans to Invest
AMD announced that it has expanded its partnership with PsiQuantum to jointly design infrastructure capable of supporting the operation of fault-tolerant, practical-scale quantum computers.
While the industry faces turmoil, "Nvidia-backed" Nscale presses ahead for NYSE listing! New IPO prospectus reveals 1,344% surge in revenue but a quarterly net loss of $1.69 billion
Nscale, a "New Cloud" provider backed by Nvidia, submitted its latest filing for an initial public offering (IPO) in the United States on Thursday.
Crypto prices
More
